Freiburg, Germany

Andrea Kropec Hübner

This inventor holds 1 USPTO granted patent. Top assignee: Albert-Ludwigs-Universitat Freiburg. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrea Kropec Hübner. Retrieved from https://idiyas.com/inventor/andrea-kropec-hübner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrea Kropec Hübner: Innovator in Immunology

Introduction

Andrea Kropec Hübner is a notable inventor based in Freiburg, Germany. She has made significant contributions to the fields of immunology and infectious diseases. Her work focuses on developing monoclonal antibodies that target Gram-positive pathogens, which are crucial for advancing medical treatments.

Latest Patents

Andrea holds a patent for "Opsonic and protective monoclonal antibodies against gram-positive pathogens." This invention pertains to antibodies that are specific for Gram-positive bacteria, particularly targeting carbohydrate structures on their surfaces. The patent includes monoclonal and chimeric antibodies, as well as their fragments and derivatives. The antibodies and peptides related to this invention have potential applications in diagnostics, prophylactics, and therapeutics.

Career Highlights

Andrea is affiliated with Albert-Ludwigs-Universität Freiburg, where she conducts her research and development. Her innovative work has led to advancements in understanding and treating infections caused by Gram-positive bacteria.

Collaborations

Andrea collaborates with esteemed colleagues, including Johannes Hübner and Friederike Rossmann, who contribute to her research endeavors.

Conclusion

Andrea Kropec Hübner's contributions to immunology through her patented inventions highlight her role as a key innovator in the fight against infectious diseases. Her work continues to pave the way for new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…